These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 1438434)
1. Incidence of bacterial contamination of bone marrow grafts. Schepers KG; Davis JM; Rowley SD Prog Clin Biol Res; 1992; 377():379-84. PubMed ID: 1438434 [No Abstract] [Full Text] [Related]
2. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course. Schwella N; Rick O; Heuft HG; Miksits K; Zimmermann R; Zingsem J; Eckstein R; Huhn D Vox Sang; 1998; 74(2):88-94. PubMed ID: 9501406 [TBL] [Abstract][Full Text] [Related]
3. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation. Incidence and clinical significance. Rowley SD; Davis J; Dick J; Braine HG; Charache P; Saral R; Sensenbrenner LL; Santos GW Transfusion; 1988; 28(2):109-12. PubMed ID: 3281332 [TBL] [Abstract][Full Text] [Related]
4. Detection of bacterial contamination in bone marrow graft. D'Antonio D; Iacone A; Fioritoni G; Dragani A; Betti S; Quaglietta AM; Di Gianfilippo R; Accorsi P; Recchia A; Di Girolamo A Haematologica; 1991 Mar; 76 Suppl 1():44-5. PubMed ID: 1864553 [TBL] [Abstract][Full Text] [Related]
5. Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts. Vanneaux V; Foïs E; Robin M; Rea D; de Latour RP; Biscay N; Chantre E; Robert I; Wargnier A; Traineau R; Benbunan M; Marolleau J; Socié G; Larghero J Cytotherapy; 2007; 9(5):508-13. PubMed ID: 17786612 [TBL] [Abstract][Full Text] [Related]
6. Contamination during in vitro processing of bone marrow for transplantation: clinical significance. Lazarus HM; Magalhaes-Silverman M; Fox RM; Creger RJ; Jacobs M Bone Marrow Transplant; 1991 Mar; 7(3):241-6. PubMed ID: 2059759 [TBL] [Abstract][Full Text] [Related]
7. [Use of bone marrow transplantation in the treatment of gastric cancer and its evaluation with special reference to anerobic Corynebacterium]. Hattori T; Yagi H; Murakami H; Ushijima K; Mori A Gan No Rinsho; 1969 Jan; 15(1):39-47. PubMed ID: 4888575 [No Abstract] [Full Text] [Related]
8. Contamination of bone marrow products with an actinomycete resembling Microbacterium species and reinfusion into autologous stem cell and bone marrow transplant recipients. Hirji Z; Saragosa R; Dedier H; Crump M; Franke N; Burrows L; Jamieson F; Brown S; Gardam MA Clin Infect Dis; 2003 May; 36(10):e115-21. PubMed ID: 12746790 [TBL] [Abstract][Full Text] [Related]
9. Germ monitoring of patients, staff and environment in reverse isolation. Hoffmann FA; Mittelstedt B; Kubel M; Helbig W Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):577-80. PubMed ID: 2480311 [TBL] [Abstract][Full Text] [Related]
11. Stopcock contamination in an ICU. McArthur BJ; Hargiss C; Schoenknecht FD Am J Nurs; 1975 Jan; 75(1):96-7. PubMed ID: 803350 [No Abstract] [Full Text] [Related]
12. Bacterial contamination of autologous bone marrow during processing. Smith D; Bradley SJ; Scott GM J Hosp Infect; 1996 May; 33(1):71-6. PubMed ID: 8738204 [TBL] [Abstract][Full Text] [Related]
13. Intensive immunotherapy with recombinant IL2 after autologous bone marrow transplantation is associated with a high incidence of bacterial infections. Blaise D; Stoppa AM; Viens P; Sainty D; Fossat C; Miquel M; Olive D; Bouabdallah R; Gabert J; Baume D Bone Marrow Transplant; 1992 Aug; 10(2):193-4. PubMed ID: 1525610 [No Abstract] [Full Text] [Related]
14. Early infections in patients undergoing bone marrow or blood stem cell transplantation--a 7 year single centre investigation of 409 cases. Krüger W; Rüssmann B; Kröger N; Salomon C; Ekopf N; Elsner HA; Kaulfers PM; Mack D; Fuchs N; Dürken M; Kabisch H; Erttmann R; Zander AR Bone Marrow Transplant; 1999 Mar; 23(6):589-97. PubMed ID: 10217190 [TBL] [Abstract][Full Text] [Related]
15. Bacteriological survey of anaerobic Corynebacterium in human bone marrow and blood. Hattori T; Mori A Gan; 1973 Feb; 64(1):7-14. PubMed ID: 4577967 [No Abstract] [Full Text] [Related]
16. [Infection problems in the leukopenia phase after autologous bone marrow transplantation]. Rusten L; Kvaløy SO; Jakobsen E; Kvalheim G; Abrahamsen AF; Høiby EA; Sandven P; Lassen J; Bruu AL Tidsskr Nor Laegeforen; 1992 May; 112(13):1723-6. PubMed ID: 1509434 [TBL] [Abstract][Full Text] [Related]
17. Bacteriological findings in patients with bone marrow transplantation (Karl Marx University Leipzig, 1985-1987). Wonitzki C; Hoffmann FA Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(3-4):569-76. PubMed ID: 2480310 [TBL] [Abstract][Full Text] [Related]
18. [Bacterial ecology in a neonatal intensive care unit]. Fanos V; Padovani EM Pediatr Med Chir; 1992; 14(3-6 Suppl):67-9. PubMed ID: 1589342 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients. Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506 [TBL] [Abstract][Full Text] [Related]
20. Reported contamination of heparin sodium with Pseudomonas putida. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(8):123-4. PubMed ID: 3080667 [No Abstract] [Full Text] [Related] [Next] [New Search]